Gemcitabine



Gemcitabine (difluorodeoxycytidine) is a chemotherapy drug that is sometimes recommended for mesothelioma. This drug belongs to a group of chemotherapy drugs called anti-metabolites. In addition to mesothelioma, it is commonly used to treat pancreatic, bladder and breast cancer.

Gemcitabine prevents cells from producing DNA and RNA by interfering with the synthesis of nucleic acids. This stops cancer cells from replicating and thus slows or stops tumor growth.


How Drug is Given
Gemcitabine is given as a drip (infusion) through a fine tube (cannula) inserted into a vein over 30 minutes. It is also given through a 'central line' (a long, hollow tube made from silicone rubber), which is inserted under the skin into a vein near the collarbone, or a 'PICC line' (a long, thin, flexible tube known as a catheter) inserted into a vein in the crook of the arm. The dose depends on patient's size and blood counts, and the cancer being treated. For lung cancer, it is usually given once a week for 3 weeks, then 1 week off.


Before you take gemcitabine

While Taking Gemcitabine
Avoid people with infections. Contact your doctor immediately if you think you might have an infection. Also contact your doctor immediately if you see unusual bleeding or bruising, blood in your urine or stools, tarry stools, or tiny red spots on the skin. Be careful not to cut yourself and avoid contact sports.

Side effects of Gemcitabine
The reaction to chemotherapy is different for each person. Some people have less side effects, while others may experience more. The side effects described here will not affect everyone who is given Gemcitabine. Also, it may be different if the patient is having more than one chemotherapy drug.
Many side effects are possible.

Common side effects include:

Occasional side effects

There can be other rare and severe side effects. Rare side effects include:

Anna L. Kaplan, M.D.